Listed

RxSight, Inc.

RXSTNasdaqCIK 1111485HealthcareFiscal year ends Dec 31

Reports and events: 85 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

RxSight, Inc., Reports and events
FiledFormWhat it isAccession number
2023-08-0716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-039068
2023-07-0506:04 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0000950170-23-031482
2023-06-0516:52 ETSC 13D/AOwnership report, active investor, amended0001193125-23-160781
2023-06-0218:30 ET8-K5.07 Shareholder vote results0000950170-23-025787
2023-05-0916:18 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019703
2023-05-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-019669
2023-04-2016:28 ETDEF 14AProxy statementPeriod 2023-06-010000950170-23-013694
2023-03-0616:09 ET10-KAnnual reportPeriod 2022-12-310000950170-23-006237
2023-03-0616:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-006234
2023-02-0809:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-027742
2023-01-0906:03 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-000394
2022-12-1213:02 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0000950170-22-026362
2022-11-0716:16 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-022617
2022-11-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-022592
2022-08-0817:05 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-215003
2022-08-0816:11 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-015528
2022-08-0816:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-015514
2022-07-1117:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-012611
2022-06-0214:41 ET8-K5.07 Shareholder vote results0000950170-22-011072
2022-05-0516:32 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007878
2022-05-0516:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-007845
2022-04-2116:02 ETDEF 14AProxy statementPeriod 2022-06-020000950170-22-005917
2022-04-0616:30 ET10-K/AAnnual report, amendedPeriod 2021-12-310000950170-22-005408
2022-03-0816:31 ET10-KAnnual reportPeriod 2021-12-310000950170-22-003135
2022-03-0816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-003130
2022-01-1006:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-000156
2022-01-0416:32 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-22-000038
2021-11-1017:02 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004155
2021-11-1016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-004078
2021-09-0917:01 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-001744
2021-09-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-001738
2021-08-1317:15 ETSC 13DOwnership report, active investor0001193125-21-246230
2021-07-2821:48 ETS-1/ARegistration statement, amended0001193125-21-226143
2021-07-2608:02 ETS-1/ARegistration statement, amended0001193125-21-223690
2021-07-0915:58 ETS-1Registration statement0001193125-21-211793

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:37 ET. Listed shows no prices and gives no investment advice.